Skip to main content
S&P 5007,720.39-0.30%DOW52,342.56-0.25%NASDAQ26,184.72-1.38%BTC$77,045.00-4.95%ETH$2,215.83-5.85%GOLD$4,026.60-0.12%OIL$102.79+0.77%
Smart Investors Daily
SID Premium
AN

NASDAQ · ANIK

Anika Therapeutics, Inc.

Healthcare · Medical - Devices

$21.79

Up+$0.24 (+1.11%)

Updated Oct 30, 2026, 5:57 AM

SID Score

5.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
207.09M
P/E ratio
-18.84
Dividend yield
0.00%
52-week range
$9.01 – $22.88
Volume
121.76K
Avg. volume
156.61K

Price performance · ANIK

ANIK price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

ANIK closed at $21.79 after 21 trading sessions, up 12.55% for the selected period.

Last close
$21.79
Period change
+12.55%
Period low
$19.10
Period high
$21.79
Daily close
View OHLC price history
ANIK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$21.56$21.85$21.36$21.79121.76K
Oct 28, 2026$21.15$21.6299$21.075$21.5597.79K
Oct 27, 2026$21.25$21.71$21.04$21.3582.94K
Oct 26, 2026$21.48$21.55$20.955$21.2796.15K
Oct 23, 2026$20.87$21.45$20.60$21.4259.2K
Oct 22, 2026$20.38$21.09$20.1111$21.0961.43K
Oct 21, 2026$20.48$20.61$20.22$20.6051.29K
Oct 20, 2026$20.22$20.63$20.11$20.44362.96K
Oct 19, 2026$19.94$20.53$19.87$20.2266.54K
Oct 16, 2026$20.73$20.75$19.84$19.9881.9K
Oct 15, 2026$20.41$20.91$20.31$20.6984.76K
Oct 14, 2026$20.34$20.61$20.12$20.2593.56K
Oct 13, 2026$20.47$20.77$20.00$20.5396.19K
Oct 12, 2026$19.53$20.69$19.325$20.47152.62K
Oct 9, 2026$19.24$19.95$19.24$19.5888.59K
Oct 8, 2026$19.39$19.39$18.90$19.23126.5K
Oct 7, 2026$19.01$19.63$18.11$19.53182.65K
Oct 6, 2026$19.73$19.80$19.05$19.1264.74K
Oct 5, 2026$19.18$19.88$19.07$19.73122.28K
Oct 2, 2026$19.41$19.47$19.01$19.1092.26K
Oct 1, 2026$19.55$19.9699$19.09$19.36111.91K

Latest ANIK news

The latest Smart Investors Daily articles mentioning ANIK.

Stock researchCompany · Overview

ANIK research

Overview

Company profile and research snapshot.

Company profile

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
ANIK recent ratings
DateFirmRatingTarget
Jul 30, 2026B. Riley SecuritiesBuy—
Feb 27, 2026Barrington ResearchOutperform—
Jan 9, 2026Barrington ResearchOutperform—
Nov 6, 2025Barrington ResearchOutperform—
Sep 23, 2025Barrington ResearchOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 22, 2026

Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026

BEDFORD, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2026 financial results before the opening of the market on Friday, November 6, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (inte

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By